CEBPB and Alzheimer disease: In our study, we identified a significant polymorphism, rs12334183, affecting a binding site for C/EBPβ, a member of the CCAAT/enhancer-binding protein family, which has been extensively studied in the context of AD due to its critical role in neuroinflammation and neurodegeneration (47).